0001213900-16-015538.txt : 20160804 0001213900-16-015538.hdr.sgml : 20160804 20160804145227 ACCESSION NUMBER: 0001213900-16-015538 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160712 FILED AS OF DATE: 20160804 DATE AS OF CHANGE: 20160804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PV Nano Cell, Ltd. CENTRAL INDEX KEY: 0001627480 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-206723 FILM NUMBER: 161806923 BUSINESS ADDRESS: STREET 1: 8 HAMASGER STREET CITY: MIGDAL HA'EMEK STATE: L3 ZIP: 2310102 BUSINESS PHONE: (972) 4-654-6881 MAIL ADDRESS: STREET 1: 8 HAMASGER STREET CITY: MIGDAL HA'EMEK STATE: L3 ZIP: 2310102 6-K 1 f6k080316_pvnanocell.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934

For the Month of July 2016

333-206723
(Commission File Number)

P.V. Nano Cell Ltd.

(Exact name of Registrant as specified in its charter)

 

8 Hamasger Street
Migdal Ha’Emek, Israel 2310102

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover
Form 20-F or Form 40-F.

 

Form 20-F þ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____

 

 

 

On July 12, 2016, P.V. Nano Cell Ltd., an Israeli corporation (the “Company”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”), pursuant to which, on July 12, 2016, the Company issued to the Investors an aggregate of 860,000 ordinary shares of the Company, par value NIS 0.01 per share (“Ordinary Shares”), at a price per Ordinary Share of $0.75. The Company received aggregate gross proceeds of $645,000 from the sale of the Ordinary Shares pursuant to the Purchase Agreement.

 

 2 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  P.V. Nano Cell Ltd.
     
Date:  August 3, 2016 By: /s/ Fernando de la Vega
    Name:  Dr. Fernando de la Vega
    Title:    Chief Executive Officer